Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

How to decide the treatment of CLL in 2015

Share :
Published: 24 Apr 2015
Views: 981
Rating:
Save
Dr Marco Montillo and Dr Maria Gomes da Silva

Dr Montillo, (Niguarda Ca’ Granda Hospital, Milan, Italy) and Dr Gomes da Silva, (Instituto Português de Oncologia de Lisboa, Lisbon, Portugal) talk to ecancertv about current haematology practices and how to decide the treatment of chronic lymphocytic leukaemia (CLL) in 2015.

They discuss how the fitness scales in publications define certain treatments for cancer patients and how new treatments are changing patient assessments.

Related Videos

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
Multiple myeloma (A cancer arising from plasma cells)
Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal
Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )
9 Nov 2023
Genomic testing: Awareness and effective communication between healthcare...
Prof Richard Simcock and Antonella Cardone
Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )
22 Oct 2023
A biomarker led approach to bladder cancer
Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...
A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )
22 Oct 2023
Systemic anti-cancer performance matrix
Prof Richard Sullivan, Kari Leung and Megan McLeod
Systemic anti-cancer performance matrix ( Prof Richard Sullivan, Kari Leung and Megan McLeod )
23 Nov 2022
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer
Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike...
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer ( Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike Schlürmann )
11 Sep 2022
An overview of treatment advances in gastric cancer
Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA
An overview of treatment advances in gastric cancer ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )
18 Aug 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation